Cargando…

FXR induces SOCS3 and suppresses hepatocellular carcinoma

Suppressor of cytokine signaling 3 (SOCS3) is regarded as a vital repressor in the liver carcinogenesis mainly by inhibiting signal transducer and activator of transcription 3 (STAT3) activity. Farnesoid X Receptor (FXR), highly expressed in liver, has an important role in protecting against hepatoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Fei, Xu, Zhizhen, Zhang, Yan, Jiang, Peng, Huang, Gang, Chen, Shan, Lyu, Xilin, Zheng, Ping, Zhao, Xin, Zeng, Yijun, Wang, Shuguang, He, Fengtian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741476/ https://www.ncbi.nlm.nih.gov/pubmed/26416445

Ejemplares similares

Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells
por: Xiong, Haojun, et al.
Publicado: (2017)

Activation of FXR protects against renal fibrosis via suppressing Smad3 expression
por: Zhao, Kai, et al.
Publicado: (2016)

Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells
por: He, Jialin, et al.
Publicado: (2015)

Upregulation of miR-124-3p by Liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and CDK6
por: Zhong, Dan, et al.
Publicado: (2020)

Chlorogenic Acid Inhibits BAFF Expression in Collagen-Induced Arthritis and Human Synoviocyte MH7A Cells by Modulating the Activation of the NF-κB Signaling Pathway
por: Fu, Xiaohong, et al.
Publicado: (2019)

Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells
por: Li, Bo, et al.
Publicado: (2016)

The prognostic role of BORIS and SOCS3 in human hepatocellular carcinoma
por: Zhao, Rongce, et al.
Publicado: (2017)

SOCS2 is a potential prognostic marker that suppresses the viability of hepatocellular carcinoma cells
por: Liu, Jiankun, et al.
Publicado: (2021)

EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling
por: Liu, Ze-Kun, et al.
Publicado: (2021)

The role of SOCS proteins in the development of virus- induced hepatocellular carcinoma
por: Xie, Jinyan, et al.
Publicado: (2021)

FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma in vitro and in vivo
por: Zhao, Kun, et al.
Publicado: (2022)

Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma
por: Khan, Md Gulam Musawwir, et al.
Publicado: (2020)

SOCS5 knockdown suppresses metastasis of hepatocellular carcinoma by ameliorating HIF-1α-dependent mitochondrial damage
por: Luo, Dingan, et al.
Publicado: (2022)

Inhibition of anti-inflammatory pathway through suppressors of cytokine signalling (Socs2/Socs3) in the initiation of hepatocellular carcinoma
por: Ashfaq, Isbah, et al.
Publicado: (2022)

Effects of valproic acid on SOCS-1, SOCS-2, SOCS-3, SOCS-5, SOCS6, and SOCS-7 gene expression and cell growth inhibition in colon carcinoma
por: Sanaei, Masumeh, et al.
Publicado: (2022)

SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma
por: Zhang, Xin, et al.
Publicado: (2015)

Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma
por: Qie, Shuo, et al.
Publicado: (2017)

FXR expression in rats of hilar cholangiocarcinoma
por: Zhang, Meng-yu, et al.
Publicado: (2022)

SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 Activation
por: Khan, Md Gulam Musawwir, et al.
Publicado: (2023)

Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1
por: Gui, Yirui, et al.
Publicado: (2017)

Magnetic Resonance Cholangiopancreatography to Evaluate Improvement Effect of FXR Regulating Bile Acid on Hepatocellular Carcinoma with Obstructive Jaundice
por: Wang, Liu, et al.
Publicado: (2022)

Activation of FXR Suppresses Esophageal Squamous Cell Carcinoma Through Antagonizing ERK1/2 Signaling Pathway
por: Feng, Qingqing, et al.
Publicado: (2021)

Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
por: Nijmeijer, Rian M., et al.
Publicado: (2011)

Celastrol-regulated gut microbiota and bile acid metabolism alleviate hepatocellular carcinoma proliferation by regulating the interaction between FXR and RXRα in vivo and in vitro
por: Zeng, Dequan, et al.
Publicado: (2023)

SOCS1: phosphorylation, dimerization and tumor suppression
por: Lessard, Frédéric, et al.
Publicado: (2019)

Socs1 and Socs3 degrades Traf6 via polyubiquitination in LPS-induced acute necrotizing pancreatitis
por: Zhou, X, et al.
Publicado: (2015)

C-Terminal Truncated HBx Facilitates Oncogenesis by Modulating Cell Cycle and Glucose Metabolism in FXR-Deficient Hepatocellular Carcinoma
por: Wu, Xuejun, et al.
Publicado: (2023)

An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma
por: Zhang, X, et al.
Publicado: (2014)

The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma
por: Cabral, Loraine Kay D., et al.
Publicado: (2021)

SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy
por: Jiang, Bei-ge, et al.
Publicado: (2015)

The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell lines
por: Li, Minle, et al.
Publicado: (2020)

Upregulation of SOCS3 in lung CD4(+) T cells in a mouse model of chronic PA lung infection and suppression of Th17-mediated neutrophil recruitment in exogenous SOCS3 transfer in vitro
por: Ding, Feng-Ming, et al.
Publicado: (2017)

Reconstruction of FXR Beam Conditions
por: Nexsen, W E, et al.
Publicado: (2001)

Coordinated Actions of FXR and LXR in Metabolism: From Pathogenesis to Pharmacological Targets for Type 2 Diabetes
por: Ding, Lin, et al.
Publicado: (2014)

SOC functions and their applications
por: Chen, Jein-Shan
Publicado: (2019)

SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma
por: Chen, Qianping, et al.
Publicado: (2022)

FXR mediates ILC-intrinsic responses to intestinal inflammation
por: Fu, Ting, et al.
Publicado: (2022)

HBV suppresses thapsigargin-induced apoptosis via inhibiting CHOP expression in hepatocellular carcinoma cells
por: Zhao, Danqi, et al.
Publicado: (2017)

Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis
por: Miyazaki, Tsuneyuki, et al.
Publicado: (2021)

miR‐206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9
por: Pang, Chi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vtfcdcrl8j5jc2eaqcb0npitrd